رجوع
نطاق اليوم
KWD 4.07
KWD 4.38
نطاق 52 أسبوعًا
KWD 1.32
KWD 5.03
حجم التداول
4,195,593
متوسط 50 يوم / 200 يوم
KWD 3.82
/
KWD 2.65
الإغلاق السابق
KWD 4.19
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -14.0 | 0.3 |
| P/B | 5.5 | 2.9 |
| ROE % | -42.3 | 3.7 |
| Net Margin % | -79.0 | 3.8 |
| Rev Growth 5Y % | 11.8 | 10.0 |
| D/E | 0.1 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 5.420
+27.8%
Low: KWD 5.250
High: KWD 5.500
ربحية السهم المستقبلية
-KWD 0.142
الإيرادات المقدّرة
120 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 0.000
KWD 0.000 – KWD 0.000
|
220 M | 0 |
| FY2029 |
KWD 0.000
KWD 0.000 – KWD 0.000
|
180 M | 0 |
| FY2028 |
-KWD 0.060
-KWD 0.062 – -KWD 0.059
|
150 M | 2 |
النقاط الرئيسية
Revenue grew 11.76% annually over 5 years — strong growth
Debt/Equity of 0.10 — conservative balance sheet
Negative free cash flow of -16.05M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 7.20%
Capital efficient — spends only 3.43% of revenue on capex
النمو
Revenue Growth (5Y)
11.76%
Revenue (1Y)18.96%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-42.25%
ROIC-29.95%
Net Margin-78.95%
Op. Margin-88.53%
الأمان
Debt / Equity
0.10
Current Ratio3.83
Interest Coverage-58.00
التقييم
P/E Ratio
-14.01
P/B Ratio5.51
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 18.96% | Revenue Growth (3Y) | 21.70% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 11.76% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 97.61M | Net Income (TTM) | -77.06M |
| ROE | -42.25% | ROA | -25.99% |
| Gross Margin | 46.85% | Operating Margin | -88.53% |
| Net Margin | -78.95% | Free Cash Flow (TTM) | -16.05M |
| ROIC | -29.95% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.10 | Current Ratio | 3.83 |
| Interest Coverage | -58.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -14.01 | P/B Ratio | 5.51 |
| P/S Ratio | 11.06 | PEG Ratio | 1.38 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.08B | Enterprise Value | 949.55M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 97.61M | 82.06M | 65.90M | 73.39M | 62.57M |
| Net Income | -77.06M | -72.49M | -133.70M | -168.72M | -32.41M |
| EPS (Diluted) | -0.31 | -0.34 | -0.65 | -0.84 | -0.19 |
| Gross Profit | 45.73M | 48.83M | 16.86M | 39.46M | 17.05M |
| Operating Income | -86.42M | -74.41M | -145.61M | -193.02M | -192.73M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 296.53M | 256.08M | 304.27M | 417.57M | 571.97M |
| Total Liabilities | 100.55M | 87.25M | 84.22M | 92.21M | 124.27M |
| Shareholders' Equity | 195.98M | 168.83M | 220.05M | 325.36M | 447.69M |
| Total Debt | 20.40M | 22.84M | 25.03M | 31.89M | 29.08M |
| Cash & Equivalents | 150.49M | 88.78M | 134.64M | 162.56M | 422.84M |
| Current Assets | 249.10M | 192.61M | 231.26M | 357.14M | 511.90M |
| Current Liabilities | 65.12M | 48.22M | 44.27M | 51.33M | 49.83M |